Detailed regimens for the prolonged β-lactam infusion therapy
-
Published:2024-07
Issue:
Volume:
Page:
-
ISSN:1341-321X
-
Container-title:Journal of Infection and Chemotherapy
-
language:en
-
Short-container-title:Journal of Infection and Chemotherapy
Reference20 articles.
1. Prolonged versus intermittent β-lactam infusion in sepsis: a systematic review and meta-analysis of randomized controlled trials;Zhao;Ann Intensive Care,2024
2. International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary
3. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis;Abdul-Aziz;Intensive Care Med,2016
4. Extended and continuous infusion of novel protected β-lactam antibiotics: a narrative review;Venuti;Drugs,2023
5. Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams;Gatti;Expert Rev Anti Infect Ther,2023